ARI-0001 CAR-T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ARI-0001 CAR-T cells, covering 2024-06-26 to 2024-06-26. Get the full timeline:
Most recent: Clinical Trial Update: Study of the Infusion of ARI-0001 Cells in Patients With CD19 + Acute Lymphoid Leukemia Resistant or Refractory to Therapy [Phase 2]